SCINAI IMMUNOTHERAPEUTICS LTD. Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent of $1.77 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net
us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent · last filed 2023-05-15
- 2023-03-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $1.77M.
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent |
|---|---|
| 2023-03-31 | $1.77M 10-Q · filed 2023-05-15 |